Clinical trials focusing on innovative approaches to post-prostatectomy urinary incontinence are set to advance with the introduction of electroacupuncture techniques. The study, titled “Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy,” has been announced by Shanghai University of Traditional Chinese Medicine with plans to begin recruitment soon, targeting patients with prostate cancer. As of November 24, 2025, the study remains in the planning phase.
What is the study about?
Post-prostatectomy urinary incontinence significantly impacts patient quality of life. Shanghai University of Traditional Chinese Medicine aims to examine whether electroacupuncture—a technique based on traditional Chinese medicine that uses electrical stimulation through acupuncture needles—can provide measurable improvement. This clinical trial expands existing research into medical device innovation for urological complications following radical prostatectomy.
What is the intervention strategy?
The study will compare two interventions: electroacupuncture and sham electroacupuncture. The electroacupuncture group will experience stimulation intended to activate specific anatomical and physiological responses linked to improved bladder control. Sham electroacupuncture serves as a control and involves needles with non-functional electrical outputs, ensuring the study adheres to robust practices for evaluating device-related efficacy and safety.
Who should pay attention?
The results of this trial are relevant for regulatory teams monitoring clinical innovations, as well as healthcare providers specializing in urology and oncology. The implications could affect treatment protocols globally if the findings show substantial improvement. Device manufacturers may also track this development for future commercialization opportunities within urotherapeutic technologies.
Frequently Asked Questions
1. What is the purpose of using electroacupuncture?
Electroacupuncture combines traditional acupuncture with electrical stimulation to target underlying causes of urinary incontinence.
2. Who will oversee compliance during the trial?
The trial is sponsored by Shanghai University of Traditional Chinese Medicine. The university will ensure its adherence to applicable medical regulatory standards.
3. When will recruitment begin?
The study was listed as “Not yet recruiting” as of November 24, 2025. Updates on recruitment timelines are expected soon.
Implications for stakeholders
This study, if successful, could mark a significant advance in addressing urinary incontinence using medical devices inspired by traditional therapies. Regulatory professionals and clinical teams should follow the developments closely for validation and future implementation opportunities.
Disclaimer
This article is intended for informational purposes only and does not constitute legal or clinical advice. Readers should consult appropriate regulatory bodies or professional counsel to address specific concerns.
Further information
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07245342?term=medical+device